Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Alphamab Co Ltd (9966 HK)
Watchlist
144
Analysis
Health Care
•
China
Alphamab Oncology produces and sells drugs. The Company manufactures and sells tumor immunobiology macromolecular targeted drug and other products. Alphamab Oncology provides services worldwide.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
07 Feb 2021 09:31
China Healthcare Weekly (Feb.5)
This article analyzed the results of the 4th volume-based purchase, the CTLA-4 antibody drug industry, the orthopedic implant device market, news...
Xinyao (Criss) Wang
Follow
454 Views
Share
bullish
•
Thematic (Sector/Industry)
•
25 Jan 2021 09:52
China Healthcare Weekly (Jan.22)
The article analyzed the new official document for the volume-based purchase,industry viewpoints on China cryogenic storage market and “AI +...
Xinyao (Criss) Wang
Follow
408 Views
Share
bullish
•
Thematic (Sector/Industry)
•
28 Dec 2020 09:42
China Healthcare Weekly (Dec.25)
This article analyzed healthcare industry viewpoints such as competitive landscape of PD-1/L1 in China, news of Alphamab, Hengrui, Innovent and...
Xinyao (Criss) Wang
Follow
530 Views
Share
bullish
•
Thematic (Sector/Industry)
•
30 Jul 2019 22:34
Greater Bay Area Initiative - Viablity & Investor Implications, Part II
Last week in Part I we discussed what the GBA Initiative is. The importance of the GBA Initiative cannot be overstated. It is critical to the...
Sharmila Whelan
638 Views
Share
bearish
•
Cross Asset Strategy
•
28 Jul 2019 13:24
🇨🇳đź‡đꇰ That Was The Week That Was • China/Hong Kong 22nd-27th July 2019 @Smartkarma
TW3 CHINA/HONG KONG 22-27 JUNEThis TW3 covers China and Hong Kong and is a companion to the North Asian TW3 published earlier today. The weight of...
Campbell Gunn
Follow
781 Views
Share
First
Previous
3
4
5
6
7
8
9
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x